Advertisement
Advertisement

PYXS

PYXS logo

Pyxis Oncology, Inc. Common Stock

2.17
USD
Sponsored
+0.07
+3.33%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

2.15

-0.02
-1.15%

PYXS Earnings Reports

Positive Surprise Ratio

PYXS beat 9 of 19 last estimates.

47%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$29.75K
/
-$0.36
Implied change from Q1 26 (Revenue/ EPS)
--
/
-2.70%
Implied change from Q2 25 (Revenue/ EPS)
-98.94%
/
+20.00%

Pyxis Oncology, Inc. Common Stock earnings per share and revenue

On May 14, 2026, PYXS reported earnings of -0.37 USD per share (EPS) for Q1 26, beating the estimate of -0.37 USD, resulting in a 1.67% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +21.24% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -0.36 USD, with revenue projected to reach 29.75 thousand USD, implying an decrease of -2.70% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, Pyxis Oncology, Inc. Common Stock reported EPS of -$0.37, beating estimates by 1.67%, and revenue of $0.00, 0% as expectations.
The stock price moved up 21.24%, changed from $2.26 before the earnings release to $2.74 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 7 analysts, Pyxis Oncology, Inc. Common Stock is expected to report EPS of -$0.36 and revenue of $29.75K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement